F/m Emerald Life Sciences Innovation ETF (LFSC) Short Interest Ratio & Short Volume

Short interest is the volume of F/m Emerald Life Sciences Innovation ETF shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 800 shares of LFSC short. Learn More on F/m Emerald Life Sciences Innovation ETF's current short interest.

F/m Emerald Life Sciences Innovation ETF saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 800 shares, a decrease of 66.7% from the previous total of 2,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to F/m Emerald Life Sciences Innovation ETF: ProShares Ultra Nasdaq Biotechnology (1.04%), Global X HealthTech ETF (0.11%), Invesco Nasdaq Biotechnology ETF (1.83%), Invesco Dorsey Wright Healthcare Momentum ETF (0.22%), Horizon Kinetics Medical ETF (0.02%), First Trust Nasdaq Pharmaceuticals ETF (0.11%), JPMorgan Healthcare Leaders ETF (0.07%), ProShares UltraShort Nasdaq Biotechnology (4.24%), Invesco S&P SmallCap Health Care ETF (0.65%), VanEck Biotech ETF (0.25%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks.

Short selling LFSC is an investing strategy that aims to generate trading profit from F/m Emerald Life Sciences Innovation ETF as its price is falling. LFSC shares are trading up $0.50 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for F/m Emerald Life Sciences Innovation ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LFSC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LFSC, twice per month. The most recent reporting period available is September, 15 2025.